The Xenon-enhanced computed tomography cerebral blood flow method

Neurosurgery

Volumn 43, Issue 6, 1998, Pages 1488-1492

  Pindzola, Ronda R ^a   Yonas, Howard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; TRACER; XENON;

BRAIN BLOOD FLOW; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

EID: 0031761430     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/00006123-199812000-00147     Document Type: Review

References (33)

1. Beristain X, Dujovny M, Gaviria M: Xenon/CT quantitative local cerebral blood flow. Surg Neurol 46:437-440, 1996.
2. Clyde BL, Resnick DK, Yonas H, Smith HA, Kaufmann AM: The relationship of blood velocity as measured by transcranial Doppler ultrasonography to cerebral blood flow as determined by stable xenon computed tomographic studies after aneurysmal subarachnoid hemorrhage. Neurosurgery 38:896-905, 1996.
3. Darby JM, Yonas H, Gur D, Latchaw RE: Xenon-enhanced computed tomography in brain death. Arch Neurol 44:551-554, 1987.
4. Darby JM, Yonas H, Pentheny S, Marion D: Intracranial pressure response to stable xenon inhalation in patients with head injury. Surg Neurol 32:343-345, 1989.
5. 2 reactivity in fulminant hepatic failure. J Cereb Blood Flow Metab 15:329-335, 1995.
6. Firlik AD, Kaufmann AM, Jungreis CA, Yonas H: Effect of transluminal angioplasty on cerebral blood flow in the management of symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 86:830-839, 1997.
7. Firlik, AD, Kaufmann AM, Wechsler LR, Firlik KS, Fukui MB, Yonas H: Quantitative cerebral blood flow determinations in acute ischemic stroke: Relationship to computed tomography and angiography. Stroke 28:2208-2213, 1997.
8. Fukui MB, Johnson DW, Yonas H, Sekhar L, Latchaw RE, Pentheny S: Xe/CT cerebral blood flow evaluation of delayed symptomatic cerebral ischemia after subarachnoid hemorrhage. AJNR Am J Neuroradiol 13:265-270, 1992.
9. Good WF, Gur D: The effect of computed tomography noise and tissue heterogeneity on cerebral blood flow determination by xenon-enhanced computed tomography. Med Phys 14:557-561, 1987.
10. Good WF, Gur D: Xenon-enhanced CT of the brain: Effect of flow activation on derived cerebral blood flow measurements. AJNR Am J Neuroradiol 12:83-85, 1991.
11. Gur D, Good WF, Wolfson SK Jr, Yonas H, Shabason L: In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. Science 215:1267-1268, 1982.
12. Halsey JH Jr, Nakai K, Wariyar B: Sensitivity of rCBF to focal lesions. Stroke 12: 631-635, 1981.
13. Hughes RL, Yonas H, Gur D, Latchaw R: Cerebral blood flow determination within the first 8 hours of cerebral infarction using stable xenon-enhanced computed tomography. Stroke 20:754-760, 1989.
14. Johnson DW, Stringer WA, Marks MP, Yonas H, Good WF, Gur D: Stable xenon/CT cerebral blood flow imaging: Rationale for and role in clinical decision making. AJNR Am J Neuroradiol 12:201-213, 1981.
15. Kaufmann AM, Firlik A, Yonas H, Wechsler L, Barch C, Fukui M, Wehner J, Spearman M, Jungreis C: Emergent stroke therapy and quantitative cerebral blood flow. Stroke 28:253, 1997 (abstr).
16. Kety SS, Schmidt CF: The nitrous oxide method for the quantitative determination of cerebral blood flow in man: Theory, procedure, and normal values. J Clin Invest 27:476-483, 1948.
17. Linskey ME, Jungreis CA, Yonas H, Hirsch WL Jr, Sekhar LN, Horton JA, Janosky JE: Stroke risk after abrupt internal carotid artery sacrifice: Accuracy of preoperative assessment with balloon test occlusion and stable Xenon-enhanced CT. AJNR Am J Neuroradiol 15:829-843, 1994.
18. Marion DW, Crosby K: The effect of stable xenon on ICP. J Cereb Blood Flow Metab 11:347-350, 1991.
19. Marks EC, Yonas H, Sanders MH, Love JT, Maxwell C, Schimmerman S: Physiologic implications of adding small amounts of carbon dioxide to the gas mixture during inhalation of xenon. Neuroradiology 34:297-300, 1992.
20. Meyer JS, Shirai T, Akiyama H: Neuro-imaging for differentiating vascular from Alzheimer's dementias. Cerebrovasc Brain Metab Rev 8:1-10, 1996.
21. Nakayama Y, Tanaka A, Kumate S, Yoshinaga S: Cerebral blood flow in normal brain tissue of patients with intracranial tumors. Neurol Med Chir (Tokyo) 36:709-714, 1996.
22. Obrist WD, Zhang Z, Yonas H: Effect of xenon-induced flow activation on Xe/CT CBF calculations. J Cereb Blood Flow Metab 18:1192-1195, 1998.
23. Stringer WA: Accuracy of xenon CT measurement of cerebral blood flow. AJNR Am J Neuroradiol 12:86-87, 1991.
24. Tanaka A, Kimura M, Nakayama Y, Yoshinaga S, Tomonaga M: Cerebral blood flow and autoregulation in normal pressure hydrocephalus. Neurosurgery 40:1161-1167, 1997.
25. Vorstrup S: Tomographic cerebral blood flow measurements in patients with ischemic cerebrovascular disease and evaluation of the vasodilatory capacity by the acetazolamide test. Acta Neurol Scand 114[Suppl]:5-48, 1988.
26. Webster MW, Makaroun MS, Steed DL, Smith HA, Johnson DW, Yonas H: Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vase Surg 21:338-345, 1995.
27. Winkler S, Turski P, Holden J, Koeppe R, Rusy B, Garber E: Xenon effects on CNS control of respiratory rate and tidal volume: The danger of apnea, in Hartman A, Hoyer S (eds): Cerebral Blood flaw and Metabolism Measurement. Berlin, Springer-Verlag, 1985, pp 356-360.
28. Witt J-P, Holl K, Heissler HE, Dietz H: Stable xenon CT CBF: Effects of blood flow alterations on CBF calculations during inhalation of 33% stable xenon. AJNR Am J Neuroradiol 12:973-975, 1991.
29. Yonas H, Darby JM, Marks EC, Durham SR, Maxwell C: CBF measured by Xe-CT: Approach to analysis and normal values. J Cereb Blood Flow Metab 11:716-725, 1991.
30. Yonas H, Gur D, Good BC, Latchaw RE, Wolfson SK Jr, Good WF, Maitz GS, Colsher JG, Barnes JE, Colliander KG, Teeter BC: Stable xenon CT blood flow mapping for evaluation of patients with extracranial-intracranial bypass surgery. J Neurosurg 62:324-333, 1985.
31. Yonas H, Sekhar L, Johnson DW, Gur D: Determination of irreversible ischemia by xenon-enhanced computed tomographic monitoring of cerebral blood flow in patients with symptomatic vasospasm. Neurosurgery 24:368-372, 1989.
32. Yonas H, Smith HA, Durham SR, Pentheny SL, Johnson DW: Increased stroke risk predicted by compromised cerebral blood flow reactivity. J Neurosurg 79:483-489, 1993.
33. Yonas H, Wolfson SK Jr, Gur D, Latchaw RE, Good WF, Leanza R, Jackson DL, Jannetta PJ, Reinmuth OM: Clinical experience with the use of xenon-enhanced CT blood flow mapping in cerebral vascular disease. Stroke 15:443-450, 1984.